On June 18, 2025, Bausch Health Companies Inc. announced that its subsidiary Bausch + Lomb priced €675 million in senior secured notes, increasing from an initially planned €600 million, to refinance existing loans and manage debt obligations. The hard closing of the offering is expected on June 26, 2025.